
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
POMC CRISPR/Cas9 KO Plasmid (r) | sc-437377 | 20 µg | $397.00 |
Proopiomelanocortin (POMC) is a neuroendocrine prohormone precursor that is proteolytically processed into multiple bioactive peptides, including ACTH and melanocortins, which coordinate stress axis signaling, energy balance, pigmentation, and nociception. In rat hypothalamic and pituitary pathways, POMC-derived peptides act through melanocortin receptors and integrate nutrient and hormonal cues to regulate feeding behavior and metabolic homeostasis. POMC expression is tightly controlled by developmental and stimulus-responsive transcriptional programs, and altered POMC processing or signaling is implicated in obesity-related phenotypes, dysregulated HPA-axis responses, and endocrine dysfunction. As a central node in neuropeptide biosynthesis and GPCR-mediated signaling, POMC is widely used to study neuroendocrine cell identity, peptide maturation, and systemic physiology.
POMC CRISPR/Cas9 KO Plasmid (r) is a pool of plasmids designed for targeted disruption of the gene in rat cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish POMC protein expression.
This CRISPR knockout system enables efficient generation of -deficient cell models for investigation of POMC signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.